papaverine and fk 409

papaverine has been researched along with fk 409 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hiraga, H; Okubo, T; Okumura, K; Suto, N; Yamamoto, T; Yoshida, IM	1

Other Studies

1 other study(ies) available for papaverine and fk 409

Article	Year
Nitric oxide donor FK409 and 8-bromoguanosine-cyclic monophosphate attenuate cardiac contractility assessed by Emax. Fundamental & clinical pharmacology, 2001, Volume: 15, Issue:2 Topics: Adrenergic beta-Antagonists; Animals; Coronary Circulation; Cyclic GMP; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Myocardial Contraction; Myocardium; Nitric Oxide Donors; Nitro Compounds; omega-N-Methylarginine; Papaverine; Propranolol; Vasodilation; Vasodilator Agents; Ventricular Function, Left	2001

Article

Year

Nitric oxide donor FK409 and 8-bromoguanosine-cyclic monophosphate attenuate cardiac contractility assessed by Emax.

Fundamental & clinical pharmacology, 2001, Volume: 15, Issue:2

Topics: Adrenergic beta-Antagonists; Animals; Coronary Circulation; Cyclic GMP; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Myocardial Contraction; Myocardium; Nitric Oxide Donors; Nitro Compounds; omega-N-Methylarginine; Papaverine; Propranolol; Vasodilation; Vasodilator Agents; Ventricular Function, Left

2001